Gildeuretinol: Audience

Gildeuretinol is an investigational oral therapy developed by Alkeus Pharmaceuticals aimed at preventing vision loss in patients with Stargardt disease and geographic atrophy. It works by reducing the accumulation of toxic vitamin A dimers in the retina without altering the visual cycle.